Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
2,802
+20
+0.7% +$1.82K 0.03% 382
2026
Q1
$286K Sell
2,782
-1,344
-33% -$152K 0.03% 359
2025
Q4
$517K Sell
4,126
-6,599
-62% -$841K 0.06% 260
2025
Q3
$1.44M Sell
10,725
-192
-2% -$25.2K 0.17% 106
2025
Q2
$1.48M Buy
10,917
+6,892
+171% +$909K 0.19% 94
2025
Q1
$534K Buy
4,025
+1,809
+82% +$230K 0.07% 221
2024
Q4
$251K Buy
+2,216
New +$256K 0.04% 311

Other funds holding ABT

Novem Group's ABT Position: Q2 2026 in Review

Novem Group increased its Abbott (ABT) stake by 0.72% in Q2 2026, buying an estimated $1.82K and bringing the position to 2,802 shares worth $254K. The position accounts for 0.03% of the portfolio, ranked #382.

Novem Group first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48M in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Novem Group held 2,802 shares of Abbott worth $254K as of Q2 2026.
  • Novem Group bought 20 Abbott shares in Q2 2026, an estimated $1.82K.
  • Abbott made up 0.03% of Novem Group's portfolio in Q2 2026, its #382 holding.
  • Novem Group first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Abbott position peaked at $1.48M in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.